Zhai et al. found that inhibition of the circIDE/miR-19b-3p/RBMS1 axis exhibited tumor-promoting activity by upregulating GPX4 to reduce iron death in hepatocellular carcinoma (Zhai et al. 2023). Here, GPX4 is linked to hepatocellular carcinoma.